Country Performance

Access to SMA medicines

Roche - Evrysdi

goodto improvenot goodEarly access or pilot programmenot authorised or not availablemissing data

Stay updated!

Newsletter sign up

Keep up-to-date with the OdySMA project. Sign up to receive our digital newsletter

OdySMA is a participatory advocacy tool. Therefore SMA Europe cannot warrant the completeness, reliability, or absolute accuracy of the data shared on OdySMA, as there may be changes that our members and supporters do not immediately inform us of. Should you identify inaccuracies or omissions, please contact us and let us know. We count on you!